The DTH effector response and IL-2 are unaffected by cyclosporine A in autoimmune B6D2F1 mice

被引:4
|
作者
MacLeod, Heather [2 ]
Goodwin, Debra G. [1 ]
Damphousse, Christy [1 ]
Lonie, Elisabeth [3 ]
Xu, Xin [3 ]
Collins, Mary [1 ]
Nickerson-Nutter, Cheryl L. [1 ]
机构
[1] Pfizer, Dept Inflammat, Cambridge, MA 02140 USA
[2] Novartis Pharmaceut, Dept Ophthalmol, Cambridge, MA USA
[3] Pfizer, Dept Drug Safety & Metab, Cambridge, MA 02140 USA
关键词
IL-2; Delayed-type hypersensitivity; Cyclosporine A; Cell signaling; Costimulation; T cells; Cytokines; mTOR; Temsirolimus; CTLA-4; DELAYED-TYPE HYPERSENSITIVITY; T-CELL PROLIFERATION; SPONTANEOUS EROSIVE ARTHRITIS; ANTIGEN-PRESENTING CELL; CYTOKINE PRODUCTION; ANTI-INTERLEUKIN-2; RECEPTOR; ACTIVATION REQUIREMENTS; LYMPHOCYTE ACTIVATION; MONOCLONAL-ANTIBODIES; GENE-EXPRESSION;
D O I
10.1016/j.cellimm.2010.08.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Delayed-type hypersensitivity (DTH) is classically defined as inflammation involving activated Th1 cells and cytokine production. DTH paw swelling, along with the cytokines IL-2, IFN gamma, MCP-1 and TNF alpha, were inhibited in Balb/c mice by cyclosporine A (CsA). Surprisingly, the DTH response in the B6D2F1 mice was unaffected by CsA, despite a decrease in TNF alpha and IFN gamma levels. IL-2 levels, however, were not decreased. To determine if the IL-2 production in the B6D2F1 strain is occurring through CD28-mediated costimulation, both CsA and CTLA-4Ig were administered. Paw swelling and IL-2 levels were decreased, indicating a role for costimulation. Co-administration of temsirolimus and CsA also reduced DTH and IL-2 levels in B6D2F1 mice, demonstrating involvement of the mTORC1 pathway. These results indicate that the cell activation pathways responsible for DTH differ with mouse strain. It is important to understand these differences in order to accurately interpret the results using potential therapeutic agents. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:14 / 23
页数:10
相关论文
共 50 条
  • [1] REPRODUCTIVE PERFORMANCE OF B6D2F1/J MICE FED DDT
    LEDOUX, TA
    LODGE, JR
    TOUCHBERRY, RW
    [J]. BIOLOGY OF REPRODUCTION, 1971, 5 (01) : 95 - +
  • [2] INHIBITION OF EJACULATORY REFLEX IN B6D2F1 MICE BY TESTOSTERONE PROPIONATE
    MCGILL, TE
    ALBELDA, SM
    BIBLE, HH
    WILLIAMS, CL
    [J]. BEHAVIORAL BIOLOGY, 1976, 16 (03): : 373 - 378
  • [3] Dissociation of circulating estrogen and vascular function with aging in B6D2F1 mice
    Zigler, Melanie L.
    Seals, Douglas R.
    Henson, Grant D.
    Lesniewski, Lisa A.
    [J]. FASEB JOURNAL, 2011, 25
  • [4] Gallium nitrate ameliorates asthma in B6D2F1/J mice.
    Apseloff, G
    LeRoy, B
    Weisbrode, SE
    Collins, J
    Gerber, N
    Mullet, D
    [J]. FASEB JOURNAL, 1996, 10 (03): : 2546 - 2546
  • [5] Differences in the immune response to long term Aβ vaccination in C57BL/6 and B6D2F1 mice
    Seabrook, TJ
    Iglesias, M
    Bloom, JK
    Spooner, ET
    Lemere, CA
    [J]. VACCINE, 2004, 22 (29-30) : 4075 - 4083
  • [6] INFLUENCE OF MURINE MELANOMA B16 ON THE DISTRIBUTION OF AMBAZONE IN B6D2F1 MICE
    AMLACHER, R
    MACKOWIAK, A
    BAUMGART, J
    SCHULZE, W
    HOFFMANN, H
    [J]. PHARMAZIE, 1990, 45 (05): : 379 - 380
  • [7] Tissue specific expression of PKR protein kinase in aging B6D2F1 mice
    Ladiges, W
    Morton, J
    Blakely, C
    Gale, M
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2000, 114 (02) : 123 - 132
  • [8] MORE ON THE CIRCADIAN MELATONIN RHYTHM IN PINEALS FROM DOMESTICATED B6D2F1 MICE
    BROWN, GM
    DELAPENA, SS
    MARQUES, N
    GROTA, LJ
    UNGAR, F
    HALBERG, F
    [J]. CHRONOBIOLOGIA, 1986, 13 (04) : 335 - 338
  • [9] INFLUENCE OF LEUKEMIA P388 ON THE PHARMACOKINETICS OF MITOGUAZONE IN B6D2F1 MICE
    AMLACHER, R
    SUHNEL, J
    BAUMGART, J
    MACKOWIAK, A
    SCHULZE, W
    BUBNER, M
    HOFFMANN, H
    [J]. PHARMAZIE, 1990, 45 (05): : 364 - 366
  • [10] ANTIGRAFT RESPONSES TO THE H-28C ANTIGEN BY B6 AND B6D2F1 MICE
    JOHNSON, LL
    [J]. IMMUNOGENETICS, 1988, 27 (03) : 159 - 166